Preventing Blood Culture Contamination

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Magnolia Medical Technologies
1 program
SteripathN/A1 trial
Active Trials
NCT02754791UnknownEst. May 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Magnolia Medical TechnologiesSteripath

Clinical Trials (1)

Reducing Blood Culture Contamination:

Start: May 2016Est. completion: May 2017
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space